Rhythm Biosciences Limited (RHY.AX)
AUD 0.07
(-4.11%)
AUD 0.07
(-4.11%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.03 AUD | 19.14% |
| 2023 | -0.04 AUD | -25.76% |
| 2022 | -0.03 AUD | 27.34% |
| 2021 | -0.04 AUD | -16.0% |
| 2020 | -0.04 AUD | -199.15% |
| 2019 | -0.01 AUD | 40.31% |
| 2018 | -0.02 AUD | -3166.67% |
| 2017 | -0.00 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q4 | -0.01 AUD | 0.0% |
| 2024 Q2 | -0.02 AUD | 0.0% |
| 2024 FY | - AUD | 19.14% |
| 2023 Q4 | -0.02 AUD | 0.0% |
| 2023 Q2 | -0.02 AUD | 0.0% |
| 2023 FY | - AUD | -25.76% |
| 2022 Q2 | -0.02 AUD | 0.0% |
| 2022 FY | - AUD | 27.34% |
| 2022 Q4 | -0.02 AUD | 0.0% |
| 2021 Q2 | -0.01 AUD | -31.82% |
| 2021 FY | - AUD | -16.0% |
| 2021 Q1 | -0.01 AUD | 50.84% |
| 2021 Q4 | -0.02 AUD | 0.0% |
| 2020 Q4 | -0.02 AUD | -103.41% |
| 2020 FY | - AUD | -199.15% |
| 2020 Q2 | -0.02 AUD | 0.0% |
| 2020 Q3 | -0.01 AUD | 46.01% |
| 2019 Q2 | -0.01 AUD | 0.0% |
| 2019 FY | - AUD | 40.31% |
| 2019 Q4 | -0.01 AUD | -69.09% |
| 2019 Q3 | -0.01 AUD | 62.33% |
| 2018 Q2 | -0.01 AUD | 0.0% |
| 2018 Q3 | -0.00 AUD | 60.16% |
| 2018 Q4 | -0.01 AUD | -118.37% |
| 2018 FY | - AUD | -3166.67% |
| 2017 FY | - AUD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Australian Clinical Labs Limited | 0.12 AUD | 125.0% |
| BCAL Diagnostics Limited | -0.03 AUD | -15.385% |
| Genetic Signatures Limited | -0.11 AUD | 72.727% |
| Genetic Technologies Limited | -0.09 AUD | 66.997% |
| Healius Limited | -0.98 AUD | 96.939% |
| Imagion Biosystems Limited | -0.41 AUD | 92.683% |
| Integral Diagnostics Limited | -0.26 AUD | 88.462% |
| INOVIQ Ltd | -0.07 AUD | 57.687% |
| Microba Life Sciences Limited | -0.05 AUD | 38.272% |
| Monash IVF Group Limited | -0.02 AUD | -78.571% |
| Sonic Healthcare Limited | 1.07 AUD | 102.804% |